Revenue: As of FY2026 Q2, the actual value is USD 49.19 M.

EPS: As of FY2026 Q2, the actual value is USD 0.1.

EBIT: As of FY2026 Q2, the actual value is USD 19.08 M.

Second Quarter 2026 Financial Highlights

• Total Revenues: $49 million, an increase of 13% year-over-year .
• Net Income Attributable to SBC Medical: $11 million, an increase of 335% year-over-year .
• Net Income Margin: 22%, an increase of 16 percentage points year-over-year .
• Adjusted EBITDA: $20 million, an increase of 32% year-over-year .
• Adjusted EBITDA Margin: 41%, an increase of 6 percentage points year-over-year .

Operational Metrics (Q2 2026)

• Number of Locations: Increased by 34 year-over-year to 287 as of June 2026 .
• Last-Twelve-Month Number of Visits: Reached 6.9 million, up 10% year-over-year .
• Average Spend Per Visit: $287, up 9% year-over-year .

First Half 2026 Financial Highlights

• Total Revenues: $92 million, an increase of 2% year-over-year .
• Net Income Attributable to SBC Medical: $22 million, a decrease of -8% year-over-year .
• Net Income Margin: 24%, a decrease of -2 percentage points year-over-year .
• Adjusted EBITDA: $38 million, a decrease of -4% year-over-year .
• Adjusted EBITDA Margin: 42%, a decrease of -2 percentage points year-over-year .
• ROE (Annualized): 17%, a decrease of -5 percentage points year-over-year .

Balance Sheet (as of June 30, 2026)

• Cash and Cash Equivalents: $184,311,213, compared to $163,773,838 as of December 31, 2025 .
• Total Assets: $406,659,022, compared to $380,447,946 as of December 31, 2025 .
• Total Liabilities: $126,743,880, compared to $117,143,240 as of December 31, 2025 .
• Total Stockholders’ Equity: $279,915,142, compared to $263,304,706 as of December 31, 2025 .

Cash Flow (Six Months Ended June 30, 2026)

• Net Cash Provided by Operating Activities: $31,741,248, compared to - $6,411,168 for the six months ended June 30, 2025 .
• Net Cash Provided by Investing Activities: $37,206, compared to $15,397,998 for the six months ended June 30, 2025 .
• Net Cash Used in Financing Activities: - $3,803,472, compared to $6,901,719 for the six months ended June 30, 2025 .

Outlook / Guidance

SBC Medical Group Holdings expects to increase service fees by approximately $15 million annually through fee revisions for call center services and expanded support for Rize Clinic and Gorilla Clinic . The company plans to deepen its multi-brand strategy in aesthetic dermatology, expand its non-aesthetic business, and accelerate global growth through collaboration with OrangeTwist and ASEAN expansion . SBC Medical Group Holdings is also preparing to enter the Longevity market and will continue disciplined investment towards its next growth phase, supported by $184 million in cash and cash equivalents .